Definitive answers, confidence in results
Definitive answers, confidence in results
Related Tests
- Healthcare Acquired Infections Alethia® C. difficile
- Pediatric & Neonatal Alethia® CMV Alethia® Group B Streptococcus
- Respiratory Alethia® Mycoplasma Direct Alethia® Pertussis Alethia® Group A Streptococcus
- Sexual Health Alethia® HSV 1&2
Support & Documents
Downloadable PDFs
Webinars & Videos
FAQs
98% sensitivity means increased detection of positives with fewer false negatives – Eliminates subjectivity related to traditional culture methods – Rapid turn around time in comparison to 48 hours for culture, allowing for proper patient management and appropriate antibiotic treatment.
Traditional culture sensitivity is as low as 90% with optimal technique – Overgrowth of normal flora –
Variability in how the specimen is attained affecting amount of streptococci growth.
Yes, a Flocked Nylon, Polyester, or Rayon swab in either Liquid Stuart or Liquid Amies, without charcoal is appropriate.
Unnecessary antibiotic treatment exposes patients to the expense and hazards which can lead to the development of antimicrobial resistance among common pathogens1. Up to 70% of patients receive antibiotic therapy while only 20%-30% have Group A Strep pharyngitis1. Estimated economic costs of pediatric streptococcal pharyngitis in the U.S. range from $224M to $539M per year.
Alethia® Group A Strep – 87651
1. Shulman et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis:2012 Update by the Infectious Diseases Society of America.
2. Alethia Group A Streptococcus Package Insert, SN11022.
Pricing
To order, Contact your regional sales representative or use the following contact information:
- Email: sales@meridianbioscience.com
- Phone: +1 800 696-0739
- International Sales Extension: +1 513 271-3000